Thymidine phosphorylase: A potential new target for treating cardiovascular disease
We recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Wei Li, Hong Yue Source Type: research
More News: Cardiology | Cardiovascular | Heart | Heart Attack | Pulmonary Thromboembolism | Stroke | Thrombosis